Indoco Remedies Limited has announced that the US FDA inspected its Active Pharmaceutical Ingredients (API) manufacturing facility at Patalganga, Navi Mumbai and has concluded with zero Form 483 observations. This is evidence of Indoco'...
.jpeg)
Datavant, the healthcare data collaboration network, has declared its strategic collaboration with Indegene to improve the effectiveness of recruitment in complicated studies.
In an interaction with Thiruamuthan, Correspondent, India Pharma Outlook, Anjali Ajaikumar, Director, Milann Fertility & Birthing Hospital, discusses the rising infertility challenge, evolving fertility treatments, and innovations shaping personalize
Eli Lilly and Company announced promising topline findings from its ACHIEVE-3 Phase 3 study, revealing that their investigational GLP-1 receptor agonist, orforglipron, which is administered orally once a day, was associated with better results...
Sai Life Sciences, a contract research, development, and manufacturing organization (CRDMO) focused on innovative medicines, announced Unit VI inauguration in Bidar, India, to manufacture veterinary active pharmaceutical...
Biocon Biologics Ltd. has received FDA approval for its denosumab biosimilars, Bosaya and Aukelso, marking a major milestone in expanding affordable biologic therapies in the U.S.
AstraZeneca has announced today landmark data from the Phase III FLAURA2 trial, demonstrating that its targeted therapy, Tagrisso (osimertinib), plus pemetrexed and platinum-based chemotherapy, achieved the longest overall survival reported in any...
AstraZeneca has received a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for a protocol being amended to widen the ongoing global clinical trial
Merck (known as MSD outside of the US and Canada) presented positive Phase 3 trial results for Capvaxive for kids at the 6th ESCMID Conference on Vaccines in Lisbon, Portugal. The STRIDE-13 study assessed the vaccine in children and adolescents...
The World Health Organization (WHO) has announced the establishment of a Guideline Development Group (GDG) to develop the first evidence-based recommendations on multiplex testing for HIV, viral hepatitis, and sexually transmitted infections (STIs)..
.jpg)
, CDSCO.jpg)